SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is drawing attention after a sharp price move and a surge in trading volume, with traders debating whether the momentum can hold or will fade like previous pumps. Bullish holders point to Flexas European expansion and payment-network utility, while skeptics emphasize the tokens steep long-term losses and question whether adoption will translate into demand.

WorldFinancial

World Liberty Financials preliminary OCC approval for a national trust bank tied to its USD1 stablecoin is fueling hopes that added legitimacy and future utility could support WLFI. The bullish case is countered by criticism of the tokens weak performance and concerns about Trump-family monetization; possible promotion around a UFC event is also discussed as speculation.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics rally is drawing attention amid reports of accelerating Eversense 365 adoption, higher revenue guidance, and progress integrating the CGM with insulin pumps. Bulls see room for the commercial momentum to continue, while skeptics point to cash burn, potential dilution, and management execution; short-squeeze and technical-breakout claims remain speculative.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Goldman Sachs return to a Buy rating has drawn attention, with traders pointing to improving Amtagvi launch execution and margins as the basis for its more optimistic view. Sentiment is broadly upbeat, though some question the analyst reversal and remain focused on an expected revenue-guidance update and upcoming NSCLC data.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Buyout speculation is dominating discussion, with traders citing BRIUMVIs commercial growth and the potential of its subcutaneous formulation ahead of a Phase 3 readout as reasons a larger pharmaceutical company might pursue TG Therapeutics. No deal is confirmed, and some traders remain skeptical amid volatile trading and competition concerns.

What Is Tezos (XTZ)?   Tezos is a high-performing blockchain and open-source platform for assets and applications, with a strong focus on code security, on-chain governance, and decentralization. Tezos 2.0, the upcoming step in the evolution of Tezos, aims to improve scalability (via layer 2s), composability, and to implement support to mainstream programming languages (like Javascript, Typescript, Python, and many others).   Initially built with formal verification in mind, the Tezos protocol enables builders to avoid bugs when developing smart contracts, making it particularly suited to applications that require a high degree of security and certainty.   Tezos’ LPoS (Liquid Proof-of-Stake) consensus mechanism enables any stakeholder to take part, directly or by delegation, in the consensus process, and to be rewarded for securing the network. Rather uniquely, Tezos’ on-chain governance system also enables stakeholders to create and vote on protocol upgrade proposals. This pioneering system allows the protocol to self-amend and upgrade itself without leading to a split (or fork) in the blockchain, empowering the community without slowing down innovation.   First proposed in 2014 and launched in 2018, the Tezos Mainnet has a proven track record of running uninterrupted ever since, having earned a strong reputation for technical excellence and a supportive community.    Who Are the Founders of Tezos? Tezos was conceived by Arthur and Kathleen Breitman in a 2014 white paper under the pseudonym L.M. Goodman in a nod to Satoshi Nakamoto, referencing a journalist who had misidentified the creator of Bitcoin.   In a previous paper, the Breitmans had argued that Bitcoin's biggest shortcomings were the lack of a governance process that invited contributions from its community of users, cost and centralization issues raised by its proof-of-work system, the limited expressiveness of its programming language which didn’t allow for smart contracts, and security

Tezos

A sharp, prolonged decline punctuated by intermittent rebounds is driving discussion of whether XTZ is bottoming or merely experiencing short-lived, possibly coordinated pumps. Bears focus on continued downside and token supply, while bulls point to potential rebounds and staking rewards; no specific confirmed catalyst dominates.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. It operates through the Hard Disk Drives (HDD) segment. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digital is drawing attention as traders debate the AI-driven demand outlook for high-capacity data-center storage, with many seeing HDDs as a beneficiary of growing data volumes and hyperscaler spending. That optimism is tempered by sharp swings and selling across memory and storage stocks, alongside concerns about rising rates and whether AI spending can sustain the trade.

iShares Bitcoin Trust ETF (The) - iShares Bitcoin Trust Beneficial Interest

iShares Bitcoin Trust ETF

Bitcoins rebound and breakout momentum are driving attention to IBIT, with traders pointing to spot ETF inflows and short covering while many expect further gains. Others warn the rally could stall near resistance or give way to a pullback, leaving the conversation split between dip-buying and caution.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma ($HELP) is drawing heavy attention amid volatile trading following a steep run-up and pullback. Traders largely attribute the rally to the appointment of a new CEO  industry veteran Eric Halstead, formerly of Intra-Cellular Therapies  with some speculating he was brought in to position the company for a sale, rather than to any new clinical results, and many characterize the pullback as profit-taking. The community is split ahead of an anticipated Phase 3 topline readout for the company's deuterated psilocybin candidate in depression: bulls point to completed Phase 3 enrollment, founder insider purchases, a TD Cowen price-target hike, and momentum across the psychedelic sector (Compass Pathways' regulatory progress, DFTX's Phase 3 GAD success, and atai-related deal activity), while bears warn of dilution risk  citing a prior $50M convertible and expectations of an offering to fund the roughly $100M+ needed to reach commercialization  and note approval remains years away. A recurring side debate pits $HELP against $CMPS over which psilocybin program is more practical, particularly around washout requirements for patients already on SSRIs.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circles planned CFO transition and co-founder Sean Nevilles board resignation are drawing attention as shares weaken. Traders disagree on the implications: some see the departures as a warning sign, while others view the CFO handover as orderly and not necessarily negative.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Is Smucker (SJM) Down 7.7% Since Last Earnings Report?

Smucker (SJM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

The J.M. Smucker Co. Portfolio Helps Consumers Get into the Fall Spirit

The J.M. Smucker Co. Portfolio Helps Consumers Get into the Fall Spirit The J.M. Smucker Co. Portfolio Helps Consumers Get into the Fall SpiritPR NewswireORRVILLE, Ohio, Sept. 25, 2026 Key TakeawaysThe J.M. Smucker Co. portfolio features brands consumers love across coffee, pet, and snacking.The...

Solventum Moves Up In Market Cap Rank, Passing J.M. Smucker

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Solventum Corp (Symbol: SOLV) has taken over the #451 spot from J.M. Smucker Co. (Symbol: SJM), according to The Online Investor.

 Market capitalization is an importan...

Can SJM's Raised 2027 Outlook Turn Earnings Momentum Into Growth?

SJM's raised fiscal 2027 earnings, sales and cash flow outlooks strengthen momentum, but broader volume growth remains key to sustaining gains.


Is SJM Worth Buying Now as Growth Engines Offset Portfolio Weakness?

SJM's double-digit Uncrustables and Cafe Bustelo growth and improving margins support earnings, even as weak snacks and soft sales test the broader portfolio.


Why Smucker (SJM) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Consumer Staples Names

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Why Smucker (SJM) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Why Smucker (SJM) is a Top Growth Stock for the Long-Term

Smucker (SJM) is a Top-Ranked Value Stock: Should You Buy?

The J. M. Smucker Co. engages in the manufacture and marketing of food and beverage products. It operates through the following segments: U.S. Retail Coffee, U.S. Retail Frozen Handheld and Spreads, U.S. Retail Pet Foods, and Sweet Baked Snacks. The U.S. Retail Coffee segment includes the domestic sales of Folgers, Dunkin’, and Café Bustelo branded coffee. The U.S. Retail Frozen Handheld and Spreads segment focuses on domestic sales of Smucker’s and Jif branded products. The U.S. Retail Pet Foods segment is involved in the domestic sales of Meow Mix, Milk-Bone, Pup-Peroni, and Canine Carry Outs branded products. The Sweet Baked Snacks segment refers to all domestic and foreign sales of Hostess and Voortman branded products in all channels. The company was founded by Jerome Monroe Smucker in 1897 and is headquartered in Orrville, OH.

J.M. Smucker Co.

Why Did SJM, REPL, NEO Stocks Surge To 52-Week Highs Today? 

Equity

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$2.55	--	--	N/A
Q1 '26	$2.22	$3.24	46.21%	BEAT
Q4 '25	$2.64	$2.77	4.98%	BEAT
Q3 '25	$2.27	$2.38	4.65%	BEAT
Q2 '25	$2.10	$2.10	-0.01%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

SJM Earnings

Upcoming Earnings: Q2 '26

Historical Earnings